Cytokine therapy for Crohn's disease: advances in translational research.
about
New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammationThe relationship between the immune system and oral manifestations of inflammatory bowel disease: a reviewMNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages.The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium.The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitisParadoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.Dietary uptake of Wedelia chinensis extract attenuates dextran sulfate sodium-induced colitis in miceHydrolysate from eggshell membrane ameliorates intestinal inflammation in miceTargeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.The potential protective role of caveolin-1 in intestinal inflammation in TNBS-induced murine colitis.Genetic deletion of IL-25 (IL-17E) confers resistance to dextran sulfate sodium-induced colitis in miceCrotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice.Harnessing regulatory T cells for the treatment of inflammatory bowel disease.Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.Th17 responses are not induced in dextran sodium sulfate model of acute colitisEffective suppression of pro-inflammatory molecules by DHCA via IKK-NF-κB pathway, in vitro and in vivo.Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced ColitisDual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors.NF-kappaB and the intestine: friend or foe?Synergistic Effect of Compounds from a Chinese Herb: Compatibility and Dose Optimization of Compounds from N-Butanol Extract of Ipomoea stolonifera.Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.Role of the JNK signal transduction pathway in inflammatory bowel disease.Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.Biological therapies for inflammatory bowel disease: controversies and future options.Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27.An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo.Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease.Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.The opioid antagonist naltrexone improves murine inflammatory bowel disease.The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis.Employing an IL-23 p19 vaccine to block IL-23 ameliorates chronic murine colitis.Gynostemma pentaphyllum saponins attenuate inflammation in vitro and in vivo by inhibition of NF-κB and STAT3 signaling.IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.FOXP3+ regulatory T-cell counts correlate with histological response in Crohn's colitis treated with infliximab.The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis.Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease
P2860
Q26823773-A24D738C-FEFC-4E2E-ABCA-5225AF160D67Q28078219-06AE0F2F-E1CA-4074-833F-0A592B1E89B4Q30445072-B6B25265-0674-4098-AC0E-873F83803901Q30454726-4A965FDB-95CD-4234-82AE-891428829BBEQ30483252-FF4A3DB2-3BB2-484A-9945-1146B3FBE490Q34396945-BD5702F1-663F-4F06-9413-48C959729969Q34755383-A055E802-B761-4151-8EF3-63EF89CEEB2EQ34834869-AA618D9F-11B1-41CA-AD67-750C737D253EQ35136750-CB54C9E9-A087-440F-AC59-53E7B0C6D662Q35163625-DDCA5F4C-B821-4D11-A0FB-D3A1B9C51AAAQ35563351-533A7151-49BC-417D-A507-4EF63BE2F20FQ35597581-A61004C5-1A47-4513-A9D7-792961172C07Q35624877-A353EFAA-8DD4-4E12-8844-4804B13F129FQ35702593-980EC827-9ED0-4BA6-A159-2C33BDFC5420Q35745537-9F43DC82-1872-45CC-9F83-2477FE992DDFQ35846206-205F9BF4-DFB4-41AA-943D-3239B8F6B76CQ35913586-F441D240-E533-4224-9F7B-D454684EFFF8Q36757136-FC4C5D98-6BF8-49A5-8EA2-7EE85C80EEC3Q36925725-4212F3B0-896F-4DBD-A670-33729AC10267Q36964798-94E247C3-4592-4A3B-9B38-190367C91358Q36994761-F4663F41-14B7-42E1-A92A-1979FC4664F0Q37054358-D905165F-2F6E-4EBF-BEDA-D2123B242E4FQ37098695-A567C2E0-A3B9-4512-AF5B-D70216859C34Q37960183-5DAB4D36-7B8D-4257-8D56-E6F17F678B15Q38918751-17B9D62B-EB75-4EBB-891B-337A6D9DFD96Q42012784-BCA7C45F-A199-4BAF-9E13-3EA12243BA2EQ42827899-C539774E-FEE6-4048-AD68-D50434CB4475Q43096293-D3DD0BC4-A7CA-4667-B50B-2CC9267E315EQ43106491-D0540AB4-3A74-4255-BEF0-BB8373003C7BQ44339195-70E357D1-38D1-4A4E-839A-C5F2A8DD8058Q44578886-AC72CF4C-022D-4CB7-8147-9A810A05187BQ46699505-DBA4C3CF-8731-49DE-A1B6-E58FF1D58C6DQ47161618-0A273816-0D44-4161-9014-6D630D1FBFBFQ49320015-45D86CA8-12A8-4812-BE76-B79680ED2532Q51776024-A91DD5C9-08F6-48E4-9013-21C4AFAD062BQ53655831-3E31C9C5-CD49-43F4-81A0-BCA578A8461BQ54536554-7ABD978B-B6D1-43A9-8E96-0ECCED877F60Q55244957-07685BC8-4320-48FA-BAF6-0F76C978FFE4Q58126740-FE74630F-E9D6-493C-B365-FC29A5109B17
P2860
Cytokine therapy for Crohn's disease: advances in translational research.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cytokine therapy for Crohn's disease: advances in translational research.
@ast
Cytokine therapy for Crohn's disease: advances in translational research.
@en
type
label
Cytokine therapy for Crohn's disease: advances in translational research.
@ast
Cytokine therapy for Crohn's disease: advances in translational research.
@en
prefLabel
Cytokine therapy for Crohn's disease: advances in translational research.
@ast
Cytokine therapy for Crohn's disease: advances in translational research.
@en
P1476
Cytokine therapy for Crohn's disease: advances in translational research.
@en
P2093
Fabio Cominelli
Theresa T Pizarro
P304
P356
10.1146/ANNUREV.MED.58.121205.100607
P577
2007-01-01T00:00:00Z